Pratz, K. W., Kaplan, J., Levy, M., Bixby, D., Burke, P. W., Erba, H., Wise-Draper, T. M., Roboz, G. J., Papadantonakis, N., Rajkhowa, T., Hernandez, D., Dobler, I., Gregory, R. C., Li, C., Wang, S., Stumpo, K., Kannan, K., Miao, H. and Levis, M. (2022) “A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia”, Haematologica. Pavia, Italy, 108(3), pp. 705-716. doi: 10.3324/haematol.2022.281216.